Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Role of DCN1 in the regulation of the VHL tumour suppressor complex

EF 2010-11

Résumé
Hypoxia-inducible factor (HIF) is a transcription factor that promotes the intracellular production of specific proteins which allow the cell to adapt to low-oxygen environments, as in solid tumours. These proteins stimulate cellular responses, including blood vessel generation and a greater capacity for anaerobic metabolism, which serve to promote tumour growth and progression. HIF is kept at relatively low levels in normal cells by von Hippel-Lindau protein (VHL) and its associated tumour suppressor complex, as it targets HIF for degradation. Mutations in VHL have been documented in the majority of clear-cell renal cell carcinomas (CCRCC), one of the most common and chemotherapy-resistant forms of kidney cancer. Therefore, normal VHL function is critical for regulation of HIF. DCN1, a newly-discovered protein found to be overproduced in certain cancers, modifies a specific component of the VHL tumour suppressor complex with a small molecule named NEDD8. The effect of this DCN1-mediated modification on VHL function has yet to be investigated. The aims of this project are (1) to determine the effect of DCN1 on the function of the VHL tumour suppressor complex, and (2) to determine the role of DCN1 in CCRCC development. We hypothesize that increased DCN1 activity leads to abnormal modification of the VHL tumour suppressor complex, thereby impairing its ability to regulate HIF, resulting in a detrimental increase in intracellular HIF levels. Intracellular production of, and interactions between, key components of this model will be examined in cultured cells containing DCN1. The results of this project may illuminate a novel, potentially carcinogenic, mode of regulation of the VHL tumour suppressor complex by DCN1. In general, a thorough understanding of cellular oncogenic mechanisms is crucial for the development of effective cancer chemotherapies.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
225374
Name
Greer Samantha N
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Role of DCN1 in the regulation of the VHL tumour suppressor complex
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer Cell Lines; Cullin-2; E3 Ligase; Gel Electrophoresis; Hypoxia-Inducible Factor; Nedd8; Sccro; Squamous Cell Carcinoma; Von Hippel-Lindau Protein; Western Blotting
Abstract
Hypoxia-inducible factor (HIF) is a transcription factor that promotes the intracellular production of specific proteins which allow the cell to adapt to low-oxygen environments, as in solid tumours. These proteins stimulate cellular responses, including blood vessel generation and a greater capacity for anaerobic metabolism, which serve to promote tumour growth and progression. HIF is kept at relatively low levels in normal cells by von Hippel-Lindau protein (VHL) and its associated tumour suppressor complex, as it targets HIF for degradation. Mutations in VHL have been documented in the majority of clear-cell renal cell carcinomas (CCRCC), one of the most common and chemotherapy-resistant forms of kidney cancer. Therefore, normal VHL function is critical for regulation of HIF. DCN1, a newly-discovered protein found to be overproduced in certain cancers, modifies a specific component of the VHL tumour suppressor complex with a small molecule named NEDD8. The effect of this DCN1-mediated modification on VHL function has yet to be investigated. The aims of this project are (1) to determine the effect of DCN1 on the function of the VHL tumour suppressor complex, and (2) to determine the role of DCN1 in CCRCC development. We hypothesize that increased DCN1 activity leads to abnormal modification of the VHL tumour suppressor complex, thereby impairing its ability to regulate HIF, resulting in a detrimental increase in intracellular HIF levels. Intracellular production of, and interactions between, key components of this model will be examined in cultured cells containing DCN1. The results of this project may illuminate a novel, potentially carcinogenic, mode of regulation of the VHL tumour suppressor complex by DCN1. In general, a thorough understanding of cellular oncogenic mechanisms is crucial for the development of effective cancer chemotherapies.
Competitiondate
201102
Approvedterm2
1 yr 0 mth
Pinamesdelim
Greer, Samantha N
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~